Table 6.

Stratified analysis of distribution of rs12998782, rs1194182 and rs10499859 alleles, and genotype frequencies in PTB patients and healthy controls according to the levels of albumin

	ALB < 40(g/L)						ALB > 40(g/L)
	Patients	Controls	OR	χ2	95% CI	P	Patients	Controls	OR	χ2	95% CI	P
	(n = 202)	(n = 216)					(n = 202)	(n = 216)
MARCO rs12998782 Genotype
CC	50	11					64	120
CT	28	5	1.232	0.126	0.389–3.906	0.723	36	72	0.952	0.036	0.576–1.575	0.849
TT	7	0	−	−	−	−	12	8	2.813	4.907	1.094–7.233	0.027*
CC + CT	78	16					100	192
TT	7	0	−	−	−	−	12	8	2.88	5.395	1.140–7.275	0.02*
Allele
C	78	16					100	192
T	92	16	1.179	0.194	0.554–2.511	0.688	124	208	1.145	0.65	0.824–1.59	0.42
CD36 rs1194182 Genotype
CC	18	3					26	49
CG	53	8	1.104	<0.0001	0.246–4.617	1	70	92	1.434	1.553	0.812–2.531	0.213
GG	15	5	0.5	0.222	0.102–2.444	0.638	16	61	0.494	3.664	0.239–1.023	0.056
CC + CG	71	11					96	141
GG	15	5	0.465	0.873	0.141–1.535	0.35	16	61	0.385	9.857	0.21–0.708	0.002*
Allele
C	89	14					122	190
G	83	18	0.725	0.69	0.339–1.551	0.406	102	214	0.742	3.186	0.535–1.03	0.074
rs10499859 Genotype
AA	35	5					42	52
AG	42	7	0.857	0.06	0.25–2.939	0.806	64	95	0.834	0.476	0.498–1.397	0.49
GG	8	4	0.286	2.799	0.062–1.31	0.094	6	53	0.14	20.052	0.055–0.385	<0.001*
AA + AG	77	12					106	147
GG	8	4	0.312	3.125	0.081–1.197	0.077	6	53	0.157	20.929	0.065–0.379	<0.001*
Allele
A	112	17					148	199
G	58	15	0.587	1.899	0.274–1.259	0.168	76	201	0.508	15.495	0.362–0.714	<0.001*

OR odds ratio, 95% CI 95% confidence interval

*P< 0.05 indicates statistical significance